Apexigen, Inc.
APGN · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9,369 | $12,730 | $14,802 | $12,708 |
| Short-Term Investments | $0 | $0 | $1,997 | $7,965 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $286 | $426 | $2,618 | $4,320 |
| Total Curr. Assets | $12,600 | $16,629 | $21,193 | $24,993 |
| Property Plant & Equip (Net) | $0 | $0 | $250 | $374 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $483 | $947 | $1,412 | $2,207 |
| Total NC Assets | $483 | $947 | $1,662 | $2,581 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13,083 | $17,576 | $22,855 | $27,574 |
| Liabilities | – | – | – | – |
| Payables | $3,381 | $2,809 | $5,343 | $3,340 |
| Short-Term Debt | $0 | $0 | $106 | $210 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $6,662 | $6,150 | $5,659 | $5,137 |
| Other Curr. Liab. | $5,362 | $5,494 | $5,359 | $8,446 |
| Total Curr. Liab. | $15,405 | $14,453 | $16,467 | $17,133 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $10 | $11 | $28 |
| Total NC Liab. | $0 | $10 | $11 | $28 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $106 | $210 |
| Total Liabilities | $15,405 | $14,463 | $16,478 | $17,161 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | -$188,893 | -$182,846 | -$176,793 | -$170,362 |
| AOCI | $0 | $0 | $0 | -$5 |
| Other Equity | $186,569 | $185,957 | $183,168 | $180,778 |
| Total Equity | -$2,322 | $3,113 | $6,377 | $10,413 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13,083 | $17,576 | $22,855 | $27,574 |
| Net Debt | -$9,369 | -$12,730 | -$14,696 | -$12,498 |